
Testing to Scale, RoboDevOps, Zenoh vs DDS: ROSCon 2024
transcript
show notes
Episode 16 of the Audrow Nash Podcast.
Three interviews from ROSCon 2024 in Denmark: Dexory scaling warehouse inventory robots and treating testing as how you ship fast, Asimovo building a Kubernetes-based RoboDevOps platform for team setups and sim compute, and ZettaScale on Zenoh as a protocol aimed at DDS's rough edges for ROS 2.
I talk with Marcus Scheunemann (head of autonomy, Dexory) about tall scanning robots for lost inventory and advocating for testing when the org wants features; with Christine Fraser (CEO & founder, Asimovo) about collaborative robotics development environments across laptop, on-prem, and cloud; and with Angelo Corsaro (CEO & CTO, ZettaScale) about Zenoh end-to-end from microcontroller to data center, discovery, and ROS 2 middleware.
You'll like this if you were at ROSCon, ship ROS 2 fleets, or care about warehouse robotics, developer platforms, or middleware. Segments: Dexory ~2:12, Asimovo ~19:22, ZettaScale / Zenoh ~44:32.
EPISODE LINKS
- ROSCon 2024: https://roscon.ros.org/2024/
- Dexory: https://www.dexory.com/
- Asimovo: https://asimovo.com/
- ZettaScale: https://www.zettascale.tech/
PODCAST LINKS
- Podcast Website: https://audrownashpodcast.com/
- YouTube: https://www.youtube.com/@audrow
- Apple Podcasts: https://podcasts.apple.com/us/podcast/audrow-nash-podcast/id1716486786
- Spotify: https://open.spotify.com/show/74jWpWiLwsasY2QHtDcl8I?si=6c92796bf9554162
TIMECODES
0:00 Cold open
2:12 Dexory: Marcus intro
3:24 Series B and scaling
6:52 Lost inventory problem
11:10 Software behind Dexory
13:58 Advocating for testing
17:18 Dexory next 2–5 years
19:22 Asimovo: Christine intro
21:17 Solutions for every setup
23:56 Diverse workflows
29:23 Clusters across platforms
34:07 Progress and adoption
40:04 One-year goals
43:09 Where to learn more
44:32 ZettaScale: Angelo intro
49:56 Distributed queries
53:07 Routing and sync
1:01:17 DDS challenges and ROS 2
1:05:29 Zenoh name story
1:07:48 ROS integration
1:13:11 Next 1–3 years






